Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,626 | 2,956 | 2,589 | 2,634 | 2,417 |
| Gross Profit | 1,626 | 2,956 | 2,589 | 2,634 | 2,417 |
| Operating Expenses | 5,177 | 5,284 | 29,935 | 6,693 | 7,853 |
| Operating Income | -3,551 | -2,329 | -27,346 | -4,058 | -5,436 |
| Interest Expense | 1 | 1 | 127 | 167 | 2 |
| Other Income | 165 | 232 | 134 | 1,045 | -5,198 |
| Pre-tax Income | -3,387 | -2,097 | -27,339 | -3,181 | -10,636 |
| Income Tax | N/A | N/A | -2,832 | -829 | -1,497 |
| Net Income Continuous | -3,387 | -2,097 | -24,508 | -2,351 | -9,139 |
| Net Income | $-3,387 | $-2,097 | $-24,508 | $-2,351 | $-9,139 |
| EPS Basic Total Ops | -0.26 | -0.27 | 4.35 | -1.73 | -10.29 |
| EPS Basic Continuous Ops | -0.26 | -0.22 | 2.05 | -1.78 | -9.56 |
| EPS Diluted Total Ops | -0.26 | -0.27 | 4.35 | -1.73 | -10.29 |
| EPS Diluted Continuous Ops | -0.26 | -0.22 | 2.05 | -1.78 | -9.56 |
| EBITDA(a) | $-3,475 | $-2,175 | $-2,785 | $-3,973 | $-5,369 |